11.56 MGBP
70.47 M
About NOVACYT EUR0.0667 (CDI)
Sector
Industry
CEO
James Martin McCarthy
Website
Headquarters
Vélizy-Villacoublay
Founded
2006
ISIN
FR0010397232
FIGI
BBG00HZV0RK3
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. It operates through the following segments: Primer Design, IT-IS International, and Corporate. The Primer Design segment focuses on the activities of Primer Design Ltd, which is a designer, manufacturer, and marketer of molecular real-time qPCR testing devices and reagents. The IT-IS International segment is involved in IT-IS International Ltd, a diagnostic instrument development and manufacturing company specializing in the development of PCR devices for the life sciences and food testing industry. The Corporate segment includes group central and corporate costs. The company was founded by Eric Peltier, Gerald Ulrich, and Jean-Pierre Crinelli on July 3, 2006 and is headquartered in Velizy-Villacoublay, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NCYT is 68.4 GBX — it has increased by 6.21% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NOVACYT EUR0.0667 (CDI) stocks are traded under the ticker NCYT.
NOVACYT EUR0.0667 (CDI) is going to release the next earnings report on Sep 26, 2024. Keep track of upcoming events with our Earnings Calendar.
NCYT stock is 12.54% volatile and has beta coefficient of 0.63. Check out the list of the most volatile stocks — is NOVACYT EUR0.0667 (CDI) there?
NOVACYT EUR0.0667 (CDI) revenue for the last quarter amounts to 54.25 M GBX despite the estimated figure of 81.30 M GBX. In the next quarter revenue is expected to reach 16.76 M GBX.
Yes, you can track NOVACYT EUR0.0667 (CDI) financials in yearly and quarterly reports right on TradingView.
NCYT stock has risen by 39.02% compared to the previous week, the month change is a 55.03% rise, over the last year NOVACYT EUR0.0667 (CDI) has showed a 25.97% increase.
Today NOVACYT EUR0.0667 (CDI) has the market capitalization of 45.32 M, it has increased by 16.41% over the last week.
No, NCYT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NCYT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVACYT EUR0.0667 (CDI) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVACYT EUR0.0667 (CDI) technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVACYT EUR0.0667 (CDI) stock shows the neutral signal. See more of NOVACYT EUR0.0667 (CDI) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.